Christopher Pieczonka

1.8k citations
69 papers · 679 · 1 hit paper · h-index 12

Impact in

Papers in

Christopher Pieczonka

58 papers receiving 663 citations

Christopher Pieczonka's Hit Papers

Improved Outcomes with Enzalutamide in Biochemically Recurrent Prostate Cancer 2023 · 114 citations
1140+1+2Years since publication255075100

Peers

Christopher Pieczonka
Comparison fields: 5 of 70
  • Urology 122
  • Pulmonary and Respiratory Medicine 433
  • Radiation 63
  • Endocrinology, Diabetes and Metabolism 98
  • Rheumatology 85
Replace A. De La Taille with:
A. De La Taille France
F. Gómez-Veiga Spain
P. Cathcart United Kingdom
Roger Paul Germany
Henriette Lindberg Denmark
Peter Hammerer Germany
Muhammad Bulbul Lebanon
Se Joong Kim South Korea
Brian Chon United States
Samuel Huang United States
Christopher Pieczonka relative to A. De La Taille France A. De La Taille's profile →
Citations per field
00.5×10×20×29×
A. De La Taille · 1×
Citations per year

Countries citing papers authored by Christopher Pieczonka

Since Specialization
Citations

This map shows the geographic impact of Christopher Pieczonka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Pieczonka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Pieczonka more than expected).

Fields of papers citing papers by Christopher Pieczonka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Pieczonka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Pieczonka. The network helps show where Christopher Pieczonka may publish in the future.

Co-authors

The 25 scholars most cited alongside Christopher Pieczonka, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Christopher Pieczonka Line = papers co-authored together Christopher Pieczonka links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 69 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Improved Outcomes with Enzalutamide in Biochemically Recurrent Prostate Cancer
Hit paper breakdown →
2023114
2 2001103
3 201782
4 202050
5 201935
6 202228
7 201623
8 202022
9 201416
10 202316
11 200114
12 202013
13 201511
14 202310
15 20189
16 20238
17 20148
18 20167
19 20187
20 20206

About Christopher Pieczonka

Christopher Pieczonka is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Radiology, Nuclear Medicine and Imaging, Cancer Research and Surgery, having authored 69 papers that have together received 679 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (57 papers), Radiopharmaceutical Chemistry and Applications (23 papers), Cancer Immunotherapy and Biomarkers (18 papers), Prostate Cancer Diagnosis and Treatment (14 papers), Cancer, Lipids, and Metabolism (7 papers), Cancer Treatment and Pharmacology (6 papers), Hormonal and reproductive studies (6 papers) and Bladder and Urothelial Cancer Treatments (4 papers). The work is most often cited by research in Urology (122 citations), Pulmonary and Respiratory Medicine (433 citations), Radiation (63 citations), Endocrinology, Diabetes and Metabolism (98 citations) and Rheumatology (85 citations). Christopher Pieczonka has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Neal D. Shore, Lawrence I. Karsh, Jack W. McAninch, Charles L. Secrest, K. Miller, Paige White, Duncan J. Summerton, David A. Hochberg, Allen F. Morey and Noel A. Armenakas. Their work appears in journals such as Journal of Clinical Oncology, The Journal of Urology, Annals of Oncology, Urologic Oncology Seminars and Original Investigations and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact